Treatment for Overt Primary Hypothyroidism
Start levothyroxine immediately at a dose based on the patient's age and cardiac status: 50-75 mcg daily for most adults under 60 years without coronary heart disease, or 12.5-25 mcg daily if over 50-60 years old or with known coronary disease. 1
Initial Dosing Strategy
With a TSH of 28 mIU/L and free T4 of 0.53 ng/dL, this represents overt primary hypothyroidism requiring prompt treatment. The guideline-recommended approach uses TSH-based dosing:
- For TSH >12 mIU/L: Start 75 mcg levothyroxine daily 1
- Age >50-60 years without coronary disease: Start 50 mcg daily 1
- Known coronary heart disease: Start 12.5-25 mcg daily 1
The lower starting doses in older patients and those with cardiac disease prevent precipitating anginal symptoms or cardiac events, which is a critical safety consideration 1.
Administration Instructions
Take levothyroxine with water 30-60 minutes before breakfast on an empty stomach to optimize absorption 1. While taking it 4 hours after the last meal at bedtime is also effective, morning dosing typically enhances compliance 1.
Key absorption interferences to avoid:
- Do not take with meals (reduces absorption by ~30%)
- Separate from calcium, iron, proton pump inhibitors, and other interfering medications by at least 4 hours 1
Monitoring and Dose Adjustment
Recheck TSH and free T4 in 4-8 weeks after starting therapy 1. This timing allows thyroid hormone levels to reach steady state. Adjust the dose in increments of 12.5-25 mcg based on TSH response 1.
The therapeutic goal is to normalize TSH to the reference range (typically 0.4-4.12 mIU/L), which serves as the most reliable endpoint 1. When TSH normalizes, free T4 will also normalize 1.
Special Considerations
Rule out adrenal insufficiency first
Although rare, patients with concurrent adrenal insufficiency require glucocorticoid replacement before starting levothyroxine to prevent precipitating adrenal crisis 1. This is particularly relevant if the patient has symptoms suggesting adrenal insufficiency or central hypothyroidism features.
Expected timeline for improvement
- TSH levels begin declining within 4 weeks with adequate dosing 2
- Most symptoms improve as TSH normalizes
- Chronic manifestations like skin changes may take 3-6 months to fully resolve 1
Common Pitfalls
Avoid overtreatment: Once stable, 20% of patients on thyroid hormone are overtreated, leading to cardiovascular complications (especially atrial fibrillation in elderly) and bone loss in postmenopausal women 1.
Monitor compliance: Non-compliance is the most common cause of persistently elevated TSH despite high levothyroxine doses (>200 mcg/day) 1. If compliance is problematic, weekly dosing can be considered 1.
Long-term monitoring
Once TSH is stable at goal, recheck every 6-12 months 1. More frequent monitoring is needed when:
- Medications affecting absorption/metabolism are added or stopped
- Significant weight changes occur
- Pregnancy occurs (increase dose by 30% immediately) 1